Bypass Budget Requests and NCI Appropriations
Bypass Budget Compared to NCI Appropriations
This graph displays the Appropriations for the NCI from fiscal years 1974 through 2019. It also displays the Budget Requests, also known as Bypass Requests, from fiscal years 1974 through 2020.
The Bypass Budget Request was not released for FY 2014, FY 2015, and FY 2018.
The FY 2017 and FY 2018 Appropriated budget includes $300,000,000 of Cancer Moonshot℠ funding.
The FY 2019 Bypass budget includes $400,000,000 of Cancer Moonshot℠ funding.
The FY 2020 Bypass budget includes $195,000,000 of Cancer Moonshot℠ funding.
NCI receives its budget from the United States Congress as part of the federal budget process for the Department of Health and Human Services and NIH.
|1938 - 2002||$52,940,982,220|
|2003||4,622,394,000||Prior to reductions in PL 108-7(-$30,046,000 for the enacted rescission and $2,000 lapse). Includes $263,442,000 of AIDS funding.|
|2004||4,770,519,000||Prior to reductions in PL 108-199(-$3,136,000 for Labor/HHS/ED rescission; $28,128,000 for across the board reduction; -$15,357,000 NIH 1% transfer assessment, and $5,000 lapse). Includes $266,975,000 of AIDS funding.|
|2005||4,865,525,000||Prior to reductions in PL 108-447($38,914,000 .8% across the board reduction; -$1,353,000 for Labor/HHS/ED rescission; -$30,505,000 NIH 1% transfer assessment, and $9,000 lapse). Includes $265,907,000 of AIDS funding.|
|2006||4,841,774,000||Prior to reductions in PL 109-149 (-$48,418,000 for Labor/HHS/ED rescission; -$3,293,000 HHS transfer for CMS activities; -$42,834,000 NIH 1% transfer for roadmap activities, and $4,000 lapse). Includes $253,866,000 of AIDS funding.|
|2007||4,797,639,000||Prior to reductions in PL 110-5 (-$5,015,000 NIH transfer for GEI activities, and $9,000 lapse). Includes $253,866,000 of AIDS funding.|
|2008||4,890,525,000||Prior to -$85,437,000 rescission and $3,091,000 in NIH transfer activities. Includes supplemental appropriation of $25,559,000. Includes $258,499,000 of AIDS funding.|
|2009||4,968,973,000||Prior to reductions in PL 111-8 (-$2,042,631 NIH transfer for activities, and $4,000 lapse). Includes $265,882,000 of AIDS funding.|
|2010||5,103,388,000||Prior to -$760,000 HHS Secretary's transfer, -$4,459,000 in NIH transfer for activities, and $22,000 lapse. Includes $272,130,000 of AIDS funding.|
|2011||5,103,388,000||Prior to -$44,810,787 recission and $472,000 lapse. Includes $269,953,000 of AIDS funding.|
|2012||5,081,788,000||Prior to $9,605,579 rescission, -$1,445,000 HHS Secretary's transfer ,-$3,342,000 HHS Secretary's transfer for Alzheimer's research, and $54,000 lapse. Includes $271,692,000 of AIDS funding.|
|2013||5,072,183,000||Prior to -$254,589,000 under sequestration (Budget Control Act, 2011, PL 112–25), -$10,144,367 recission, -$28,044,000 HHS Secretary's transfer and +$9,714,000 restored from the National Children's Study and National Eye Institute HIV/AIDS funding, and $106,000 lapse. Includes $261,550,000 of AIDS funding.|
|2014||4,923,238,000||Prior to -$12,359,000 HHS Secretary's transfer,-$965,000 HHS Secretary’s Cybersecurity Transfer (authorized by section 206 of P.L. 113-76), +$16,180,552 transfer from National Children's Study, and +$6,307,000 transfer from NIH Office of AIDS Research, and $33,000 lapse. Includes $269,212,000 of AIDS funding.|
|2015||4,950,396,000||Prior to +$2,632,000 transfer from NIH Office of AIDS Research and $435,000 lapse. Includes $269,660,000 of AIDS funding.|
|2016||5,214,701,000||Prior to -$7,217,390 HHS Secretary's transfer, -$1,192,000 transfer to NIH Office of AIDS Research, and $122,000 lapse. Includes $266,422,000 of AIDS funding.|
|2017||5,689,329,000||Prior to -$11,971,000 HHS Secretary's transfer, -$17,403,000 transfer to NIH Office of AIDS Research, and $247,000 lapse. Includes $249,019,000 of AIDS funding and $300,000,000 of Cancer Moonshot℠ funding.|
|2018||5,964,800,000||Prior to -$13,309,000 HHS Secretary's transfer, -$7,785,000 transfer to NIH Office of AIDS Research, and $250,000 lapse. Includes $241,234,000 of AIDS funding and $300,000,000 of Cancer Moonshot℠ funding.|
|1938 - 2018||$133,801,542,220|
Professional Judgment (Bypass) Budget Requests
The National Cancer Act of 1971 (P.L. 92-218) gives NCI special authority to submit an annual budget estimate directly to the President. Each year, NCI develops the Professional Judgment Budget, commonly known as the Bypass Budget, which reflects NCI cancer research priorities and identifies areas of potential investment in cancer research. NCI submitted its first Professional Judgment Budget, often referred to as the Bypass Budget, for the FY 1974 request.
The NCI Bypass Budget authority in section 407 of the National Cancer Act states:
The Director of the Institute in carrying out the National Cancer Program [shall] prepare and submit, directly to the President for review and transmittal to Congress, an annual budget estimate (including an estimate of the number and type of personnel needs for the Institute) for the National Cancer Program, after reasonable opportunity for comment (but without change) by the Secretary [of the Department of Health and Human Services], the Director of NIH, and the Institute's advisory council.
The table below shows Budget Requests during the past 10 years. To view previous Budget Requests, dating back to 1974, please download the data.
|* The Bypass Budget Request was not released for FY 2014, FY 2015, and FY 2018.|
|** Includes $400,000,000 of FY 2019 Cancer Moonshot℠ funding.|
|*** Includes $195,000,000 of FY 2020 Cancer Moonshot℠ funding.|